NumbSkin Pain Relief Cream Recalled by SeeNext Venture
NumbSkin Pain Relief Cream Recalled by SeeNext Venture Due to Failure to Meet Child Resistant Packaging Requirement; Risk of Poisoning (Recall Alert)
Why was NumbSkin Pain Relief Cream Recalled by SeeNext Venture recalled?
The packaging is not child resistant as required by the Poison Prevention Packaging Act. The pain relieving cream contains lidocaine, posing a risk of poisoning to young children if they put it on their skin or ingest it.
What should I do if I have this product?
Consumers should immediately store the pain relief cream in a safe location out of reach of children and contact SeeNext Venture for instructions on how to dispose or return it and to receive a free replacement similar product with a child-resistant cap. Amazon is contacting all known purchasers directly. Contact: SeeNext Venture toll-free at 844-700-6862 from 9 a.m. to 6 p.m. PT Monday through Saturday, email at [email protected] or online at www.numbskin.com and click on Recall at the home page for more information.
What to do with a recalled product: refunds, receipts, safe disposal and how to report a problem.
Is my product affected?
Compare the item in your hand with every identifier below from the official CPSC record. Only products that match the listed product and identifiers are part of this recall.
- Product
- NumbSkin pain relief cream with lidocaine
- Company
- SeeNext Venture Ltd., of Blaine, Wash.
- Quantity
- About 8,000
- Sold at
- Online at Amazon.com from October 2019 through February 2020 for about $25.
- Recall date
- March 18, 2020
- Incidents / injuries
- None reported.
- Agency
- CPSC
Product description
This recall involves NumbSkin pain relief cream with 5% lidocaine. The topical anesthetic cream was sold in 30 grams in a white with blue tube. NumbSkin is printed on the tube. Lot 9238 and a date code of 10/2019 through 09/2020 in a MM/YYYY format is embossed on the tub's thin end. Batch number 9238 is printed on the product packaging.